What is driving NOVN.SW stock pre-market activity today?

Pre-market interest in NOVN.SW stock stems from near-term earnings on 04 Feb 2026, a tight trading range near the year high CHF117.14, and higher-than-average volume of 3,341,409.00 shares that is drawing active traders to the name.

How does Novartis trade versus sector peers on valuation?

Novartis trades at P/E **20.26**, below the Swiss healthcare sector average P/E of about **34.64**, signaling relatively cheaper valuation versus peers while offering a roughly **3.00%** dividend yield.

What price targets does Meyka AI show for NOVN.SW stock?

Meyka AI's forecast model projects a monthly target of **CHF123.14** (implied upside **+5.68%**) and a one-year projection of **CHF108.32** (implied downside **-7.02%**). Forecasts are model-based projections and not guarantees.

What technical levels should traders watch in pre-market trading?

Traders should monitor RSI **74.23** (overbought), the 50-day average at **CHF109.08** as immediate support, and intraday volume spikes above **2,965,242.00** average volume for breakout confirmation.

CH Stocks

CHF116.52 pre-market: Novartis AG (NOVN.SW) on SIX 28 Jan 2026 watch earnings

ByHuzaifa Zahoor January 28, 2026

We see NOVN.SW stock trading at CHF116.52 in pre-market action on the SIX as volume runs at 3,341,409.00 shares, making Novartis one of the most active names this session. The move keeps the price near its year high CHF117.14 and ahead of an earnings event on 04 Feb 2026. Market participants are watching valuation and catalysts: P/E sits at 20.26 and EPS at 5.75, while the healthcare sector shows stronger YTD performance. Meyka AI provides this pre-market snapshot and near-term context for traders and investors